Medical cost analysis: Application to colorectal cancer data from the SEER Medicare database

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Incompleteness is a key feature of most survival data. Numerous well established statistical methodologies and algorithms exist for analyzing life or failure time data. However, induced censorship invalidates the use of those standard analytic tools for some survival-type data such as medical costs. In this paper, some valid methods currently available for analyzing censored medical cost data are reviewed. Some cautionary findings under different assumptions are envisioned through application to medical costs from colorectal cancer patients. Cost analysis should be suitably planned and carefully interpreted under various meaningful scenarios even with judiciously selected statistical methods. This approach would be greatly helpful to policy makers who seek to prioritize health care expenditures and to assess the elements of resource use.

Original languageEnglish (US)
Pages (from-to)586-597
Number of pages12
JournalContemporary Clinical Trials
Volume26
Issue number5
DOIs
StatePublished - Oct 2005
Externally publishedYes

Fingerprint

Medicare
Colorectal Neoplasms
Databases
Costs and Cost Analysis
Survival
Health Expenditures
Administrative Personnel
Delivery of Health Care

Keywords

  • Censoring
  • Colorectal cancer
  • Composite endpoints
  • Inverse probability weighting
  • Median regression
  • Medical cost

ASJC Scopus subject areas

  • Pharmacology

Cite this

Medical cost analysis : Application to colorectal cancer data from the SEER Medicare database. / Bang, Heejung.

In: Contemporary Clinical Trials, Vol. 26, No. 5, 10.2005, p. 586-597.

Research output: Contribution to journalArticle

@article{b8256f452a794687a1e09a5abb986569,
title = "Medical cost analysis: Application to colorectal cancer data from the SEER Medicare database",
abstract = "Incompleteness is a key feature of most survival data. Numerous well established statistical methodologies and algorithms exist for analyzing life or failure time data. However, induced censorship invalidates the use of those standard analytic tools for some survival-type data such as medical costs. In this paper, some valid methods currently available for analyzing censored medical cost data are reviewed. Some cautionary findings under different assumptions are envisioned through application to medical costs from colorectal cancer patients. Cost analysis should be suitably planned and carefully interpreted under various meaningful scenarios even with judiciously selected statistical methods. This approach would be greatly helpful to policy makers who seek to prioritize health care expenditures and to assess the elements of resource use.",
keywords = "Censoring, Colorectal cancer, Composite endpoints, Inverse probability weighting, Median regression, Medical cost",
author = "Heejung Bang",
year = "2005",
month = "10",
doi = "10.1016/j.cct.2005.05.004",
language = "English (US)",
volume = "26",
pages = "586--597",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Medical cost analysis

T2 - Application to colorectal cancer data from the SEER Medicare database

AU - Bang, Heejung

PY - 2005/10

Y1 - 2005/10

N2 - Incompleteness is a key feature of most survival data. Numerous well established statistical methodologies and algorithms exist for analyzing life or failure time data. However, induced censorship invalidates the use of those standard analytic tools for some survival-type data such as medical costs. In this paper, some valid methods currently available for analyzing censored medical cost data are reviewed. Some cautionary findings under different assumptions are envisioned through application to medical costs from colorectal cancer patients. Cost analysis should be suitably planned and carefully interpreted under various meaningful scenarios even with judiciously selected statistical methods. This approach would be greatly helpful to policy makers who seek to prioritize health care expenditures and to assess the elements of resource use.

AB - Incompleteness is a key feature of most survival data. Numerous well established statistical methodologies and algorithms exist for analyzing life or failure time data. However, induced censorship invalidates the use of those standard analytic tools for some survival-type data such as medical costs. In this paper, some valid methods currently available for analyzing censored medical cost data are reviewed. Some cautionary findings under different assumptions are envisioned through application to medical costs from colorectal cancer patients. Cost analysis should be suitably planned and carefully interpreted under various meaningful scenarios even with judiciously selected statistical methods. This approach would be greatly helpful to policy makers who seek to prioritize health care expenditures and to assess the elements of resource use.

KW - Censoring

KW - Colorectal cancer

KW - Composite endpoints

KW - Inverse probability weighting

KW - Median regression

KW - Medical cost

UR - http://www.scopus.com/inward/record.url?scp=24144454860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144454860&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2005.05.004

DO - 10.1016/j.cct.2005.05.004

M3 - Article

C2 - 16084777

AN - SCOPUS:24144454860

VL - 26

SP - 586

EP - 597

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

IS - 5

ER -